JHULI PATEL: Open Payments
NPI 1588735625 · NORTH BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,114 in 103 payments from 16 companies in 2025. Trend: 2023 $630 · 2024 $1,026 · 2025 $2,114
Food & beverage: $2,020Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $486 |
| ABBVIE INC. | 21 | $438 |
| Madrigal Pharmaceuticals | 16 | $351 |
| QOL Medical, LLC | 10 | $211 |
| PFIZER INC. | 12 | $186 |
| Phathom Pharmaceuticals, Inc. | 9 | $97 |
| Intercept Pharmaceuticals, Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, Sucraid, RINVOQ, VELSIPITY, VOQUEZNA, XELJANZ.
Industry payments across NJ — which companies pay providers there.
